References
Alexandrides, T.; Moses, A. C.; Smith, R. J. Developmental expression of receptors for insulin, insulin-like growth factor I (IGF-I), and IGF-II in rat skeletal muscle. Endocrinology 124:1064–1076; 1989.
Ballesteros, M.; Scott, C. D.; Baxter, R. C. Developmental regulation of insulin-like growth factor-II/mannose 6-phosphate receptor mRNA in the rat. Biochem. Biophys. Res. Commun. 172:775–779; 1990.
Bernacki, R. J.; Niedbala, M. J.; Korytnyk, W. Glycosidases in cancer and invasion. Cancer Metastasis Rev. 4:81–85; 1985.
Fleck, J. F.; Sledge, G. W., Jr.; Benenati, S. V., et al. Binding of insulin-like growth factors to Tera-2 human embryonal carcinoma cells during differentiation. Cancer Res. 51:4395–4401; 1991.
Fraslon, C.; Bourbon, J. R. Comparison of effects of epidermal and insulin-like growth factors, gastrin releasing peptide and retinoic acid on fetal lung cell growth and maturation in vitro. Biochem. Biophys. Acta 1123:65–75; 1992.
Heinz-Erian, P.; Kessler, U.; Funk, B., et al. Identification and in situ localization of the insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptor in the rat gastrointestinal tract: comparison with the IGF-I receptor. Endocrinology 129:1769–1778; 1991.
Kamio, T.; Shigematsu, K.; Kawai, K., et al. Immunoreactivity and receptor expression of insulin-like growth factor I and insulin in human adrenal tumors. Am. J. Pathol. 138:83–91; 1991.
Kiess, W.; Blickenstaff, G. D.; Sklar, M. M., et al. Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-dependent mannose 6-phosphate receptor. J. Biol. Chem. 263:9339–9344; 1988.
Kornfeld, S. Trafficking of lysosomal enzymes. FASEB J. 1:462–464; 1987.
Laburthe, M.; Rouyer-Fessard, C.; Gammeltoft, S. Receptors for the insulin-like growth factors I and II in rat gastrointestinal epithelium. Am. J. Physiol. 254:G457-G462; 1988.
Lambert, S.; Vivario, J.; Boniver, J., et al. Abnormal expression and structural modification of the insulin-like growth factor-II gene in human colorectal tumors. Int. J. Cancer 46:405–410; 1990.
MacDonald, R. G.; Tepper, M. A.; Clairmont, K. B., et al. Serum form of the rat insulin-like growth factor II/mannose 6-phosphate receptor is truncated in the carboxyl-terminal domain. J. Biol. Chem. 264:3256–3261; 1989.
Massague, J.; Kelley, B.; Mottola, C. Stimulation by insulin-like growth factors is required for cellular transformation by type B transforming growth factor. J. Biol. Chem. 2360:4531–4554; 1985.
Morgan, D. O.; Edman, J. C.; Standring, D. N., et al. Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 329:301–307; 1987.
Nissley, P.; Kiess, W.; Sklar, M. M. The insulin-like growth factor/mannose-6-phosphate receptor. In: LeRoith, D., ed. Insulin-like growth factors: molecular and cellular aspects. Boca Raton: CRC Press; 1991:111–150.
Osborne, C. K.; Coronado, E. B.; Kitten, L. J., et al. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol. Endocrinol. 3:1701–1709; 1989.
Park, J. H. Y.; Vanderhoof, J. A.; Blackwood, D., et al. Characterization of type I and type II insulin-like growth factor receptors in an epithelial cell line. Endocrinology 126:2998–3005; 1990.
Polychronakos, C.; Guyda, H. J.; Janthly, U., et al. Effects of mannose 6-phosphate on receptor-mediated endocytosis of insulin-like growth factor-II. Endocrinology 127:1861–1866; 1990.
Polychronakos, C.; Janthly, U.; Lehoux, J-G., et al. Mitogenic effects of insulin and insulin-like growth factors on PA-III rat prostate adenocarcinoma cells: characterization of the receptors involved. Prostate 19:313–321; 1991.
Rochefort, H.; Augereau, P.; Briozzo, P., et al. Structure, function, regulation and clinical significance of the 52K procathespin D secreted by breast cancer cells. Biochemie 70:943–949; 1988.
Sellner, F. Investigations on the significance of the adenoma-carcinoma sequence in the small bowel. Cancer 66:702–715; 1990.
Singer, B.; Grunberger, D. Molecular biology of mutagens and carcinogens. New York: Plenum Press; 1983.
Tatsuta, M.; Iishi, H.; Baba, M., et al. Attenuating effect of the monoamine oxidase inhibitor furazolidone on the anti-carcinogenic effect of cysteamine on gastric carcinogenesis induced by n-methyl-n1-nitro-nitrosoguanidine in Wistar rats. Int. J. Cancer 48:605–608; 1991.
Thornton, W. H., Jr.; Terry, B. E.; MacDonald, R. S., et al. Sucrase, alkaline phosphatase, and IGF-II receptors are present in atrophied small intestine 12 years after bypass surgery. J. Am. Coll. Nutr. 10:543; 1991.
Thornton, W. H., Jr.; MacDonald, R. S. Identification of IGF-2 receptors in cultured cells by flow cytometry. Presented at the 73rd Annual Meeting of the Endocrine Society, 1991.
Tremollieres, F. A.; Strong, D. D.; Baylink, D. J., et al. Insulin-like growth factor II and transforming growth factorβ1 regulate insulin-like growth factor I secretion in mouse bone cells. Acta. Endocrinol. 125:538–546; 1991.
Tricoli, J. V.; Rall, L. B.; Karakousis, C. P., et al. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res. 46:6169–6173; 1986.
Zvibel, I.; Halay, E.; Reid, L. M. Heparin and hormonal regulation of mRNA synthesis and abundance of autocrine growth factors: relevance to clonal growth of tumors. Mol. Cell Biol. 11:108–116; 1991.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thornton, W.H., MacDonald, R.S. & Barnett, L. Insulin-like growth factor-II receptor expression in normal and N-methyl-N′-nitro-nitrosoguanidine exposed cell lines: Assessment by flow cytometry. In Vitro Cell Dev Biol - Animal 29, 114–116 (1993). https://doi.org/10.1007/BF02630940
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02630940